Inzy stock forecast.

View today's Inozyme Pharma Inc stock price and latest INZY news and analysis. Create real-time notifications to follow any changes in the live stock price.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceFind the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceBased on 12 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $82.64 with a high forecast of $93.00 and a low forecast of $63.00. The average price target represents a 53.24% change from the last price of $53.93. Highest Price Target $93.00. Average Price Target $82.64.Nov 20, 2023 · Target values for the price of one Incyte share for Jan 2025. The weighted average target price per Incyte share in Jan 2025 is: 59.50. In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.054% volatility is expected. Pessimistic target level: 56.44. Optimistic target level: 60.73.

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.

View real-time stock prices and stock quotes for a full financial overview. ... Incyte’s Financial Performance and Future Outlook: An Analysis of Key Products and Revised Estimates

Delayed Data. As of Nov 16. +0.03 / +0.94%. Today’s Change. 0.99. Today ||| 52-Week Range. 7.33. +207.62%. Year-to-Date.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...Sep 20, 2023 · Inozyme Pharma, Inc. (INZY) share price prediction for 2023, 2024, 2025, 2026 and 2027. INZY one year forecast. Inozyme Pharma stock monthly and weekly forecasts. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ... Find the latest China SXT Pharmaceuticals, Inc. (SXTC) stock quote, history, news and other vital information to help you with your stock trading and investing.

View Avis Budget Group, Inc CAR investment & stock information. Get the latest Avis Budget Group, Inc CAR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Find the latest Avenue Therapeutics, Inc. (ATXI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Plus, catch 5 New Zacks Strong Buy Stocks, Bull Stock of the Day, and more in the Profit from the Pros e-newsletter. Today, you will also get Zacks' 7 Best Stocks for the Next 30 Days. It's free ...APP | Complete Applovin Corp. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average ...According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $15.00 with a high price target of $23.00 and a low price target of $6.00. Learn more on INZY's analyst rating history.

Oct 27, 2023 · Price Prediction Incyte price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. Tesla, Inc. - Sell. Zacks' proprietary data indicates that Tesla, Inc. is currently rated as a Zacks Rank 5 and we are expecting a below average return from the TSLA shares relative to the market ...Dec 1, 2023 · Website. 2015. 56. Doug Treco. https://www.inozyme.com. Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company’s lead product candidate is INZ-701, a soluble, recombinant, genetically ... Find the latest Kintara Therapeutics, Inc. (KTRA) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Forecast. According to 4 analysts, the average rating for INZY stock is "Strong Buy." The 12-month stock price forecast is $15.0, which is an …

Dec 1, 2023 · 19 Wall Street analysts have issued 1-year price objectives for Incyte's stock. Their INCY share price targets range from $61.00 to $100.00. On average, they expect the company's share price to reach $79.94 in the next year. This suggests a possible upside of 48.0% from the stock's current price. Find the latest Gaotu Techedu Inc. (GOTU) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 27, 2023 · Incyte Corp Revenue Forecast for 2023 - 2025 - 2030. Incyte Corp's Revenue has seen impressive growth In the last three years, rising from $2.16B to $3.39B – a growth of 57.25%. In the next year, analysts believe that Revenue will reach $3.93B – an increase of 15.71%. For the next eight years, the forecast is for Revenue to grow by 16.18%. Website. 2015. 56. Doug Treco. https://www.inozyme.com. Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company’s lead product candidate is INZ-701, a soluble, recombinant, genetically ...INZY Stock 12 Months Forecast. $16.00. (315.58% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Inozyme Pharma in the last 3 months. The …Based on short-term price targets offered by 16 analysts, the average price target for Incyte comes to $75.44. The forecasts range from a low of $59.00 to a high of $93.00. The average price ...View the latest Inozyme Pharma Inc. (INZY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...Read Full Company Summary for INCY here. View Incyte Corporation INCY investment & stock information. Get the latest Incyte Corporation INCY detailed stock quotes, stock data, Real-Time ECN ...

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.

Analyst Forecast According to 4 analysts, the average rating for INZY stock is "Strong Buy." The 12-month stock price forecast is $15.0, which is an increase of 306.50% from the latest price.

Find the latest OKYO Pharma Limited (OKYO) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Mobile Global Esports Inc. (MGAM) stock quote, history, news and other vital information to help you with your stock trading and investing.At the time of writing, Incyte Corp. [INCY] stock is trading at $54.34, up 1.78%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INCY shares have gain 1.76% over the last week, with a monthly amount glided 0.76%, and seem to be holdingThe core CPI, excluding food and energy, rose 4.8% from the prior year, also slowing from 5.3% in May and below the consensus forecast. The Dow rose 0.8%, the S&P 1.0%, and the Nasdaq 1.4%. Crude ...Find the latest Pop Culture Group Co., Ltd (CPOP) stock quote, history, news and other vital information to help you with your stock trading and investing.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...President exercised options and sold US$65k worth of stock Jun 26. Inozyme Pharma, Inc. Announces Acceptance of First European Clinical Trial Application …Analyst Forecast According to 16 analysts, the average rating for INCY stock is "Buy." The 12-month stock price forecast is $79.25, which is an increase of 46.71% from the latest price.Price Action: INZY shares are up 26.6% at $2.81 during the premarket session on the last check Thursday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free!Find the latest Vaxart, Inc. (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest SciSparc Ltd. (SPRC) stock quote, history, news and other vital information to help you with your stock trading and investing.

APP | Complete Applovin Corp. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ... Find the latest Mobile Global Esports Inc. (MGAM) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. nktx stock forecastptnqqngy stocktwitsdoes nvidia pay a dividend Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinancePlanning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas... equity trust brokerage4 week treasury bill Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ... vps for trading The weighted average target price per Incyte share in Dec 2023 is: 52.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 3.880% volatility is expected. Pessimistic target level: 51.04. Optimistic target level: 53.10. Incyte stock price predictions for 2023 using artificial intelligence.Nov 24, 2023 · The Incyte Corporation stock price gained 0.637% on the last trading day (Friday, 24th Nov 2023), rising from $53.40 to $53.74. During the last trading day the stock fluctuated 1.08% from a day low at $53.21 to a day high of $53.78. The price has risen in 7 of the last 10 days and is up by 2.32% over the past 2 weeks.